Vincere Biosciences

Our September meeting continued virtual by member preference.

Beacon members entertained a new funding proposal from Vincere Biosciences, which is developing small molecule therapeutics targeting mitochondrial quality control to cure age-related and neurodegenerative diseases.

Members reported on companies in due diligence consisting of:

  • Ocular Technologies, and
  • RevMedica.

We heard updates on new or renewed funding rounds for:

  • Diesel Labs,
  • First Light Diagnostics,
  • Theromics, and
  • GelMEDIX.

About Angel Treaty

Dedicated to fostering due diligence sharing between angel groups.
This entry was posted in Uncategorized. Bookmark the permalink.